Validation studies of claims data in the Asia‐Pacific region: A comprehensive review

Koram, Nana; Delgado, Megan; Stark, James H.; Setoguchi, Soko; Luise, Cynthia de

doi:10.1002/pds.4616

Cited by 33 publications

(50 citation statements)

References 46 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…There have been a number of validation studies on diabetes‐related complications, with most having assessed the accuracy of ICD‐10 codes 19,21,22 . Combinations of ICD‐10 codes also improved the accuracy of diagnosis of acute myocardial infarction 39 and renal failure 30 .…”

Section: Discussionmentioning

confidence: 99%

“…In Japan claims data are recorded electronically using unique master codes 18 . While the use of claims data for epidemiologic research has increased, validation studies are limited regarding the use of those data for studies of micro/macrovascular diabetes‐related complications in Japan compared with other countries 19,20 …”

Section: Introductionmentioning

confidence: 99%

“…Although there have been several validation studies on the use of claims data with regard to diabetes‐related complications conducted around the world, accuracy varies across studies 19,21,22 . The positive predictive value (PPV) was 0.45–0.99 for acute myocardial infarction, 22‐24 0.76–0.98 for heart failure, 22,24‐26 0.76–0.92 for cerebrovascular disease, 22,27‐29 and 0.60–0.97 for renal failure 30,31 .…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Accuracy of Japanese claims data in identifying diabetes‐related complications

Fujihara

Yamada-Harada

Matsubayashi

et al. 2021

Pharmacoepidemiology and Drug

View full text Add to dashboard Cite

Purpose To evaluate the accuracy of various claims‐based definitions of diabetes‐related complications (coronary artery disease [CAD], heart failure, cerebrovascular disease and dialysis). Methods We evaluated data on 1379 inpatients who received care at the Niigata University Medical & Dental Hospital in September 2018. Manual electronic medical chart reviews were conducted for all patients with regard to diabetes‐related complications and were used as the gold standard. Sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of each claims‐based definition associated with diabetes‐related complications based on Diagnosis Procedure Combination (DPC), International Classification of Diseases, Tenth Revision (ICD‐10) codes, procedure codes and medication codes were calculated. Results DPC‐based definitions had higher sensitivity, specificity, and PPV than ICD‐10 code definitions for CAD and cerebrovascular disease, with sensitivity of 0.963–1.000 and 0.905–0.952, specificity of 1.000 and 1.000, and PPV of 1.000 and 1.000, respectively. Sensitivity, specificity, and PPV were high using procedure codes for CAD and dialysis, with sensitivity of 0.963 and 1.000, specificity of 1.000 and 1.000, and PPV of 1.000 and 1.000, respectively. DPC and/or ICD‐10 codes + medication were better for heart failure than the ICD‐10 code definition, with sensitivity of 0.933, specificity of 1.000, and PPV of 1.000. The PPVs were lower than 60% for all diabetes‐related complications using ICD‐10 codes only. Conclusion The DPC‐based definitions for CAD and cerebrovascular disease, procedure codes for CAD and dialysis, and DPC or ICD‐10 codes with medication codes for heart failure could accurately identify these diabetes‐related complications from claims databases.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Accuracy of Japanese claims data in identifying diabetes‐related complications

Fujihara

Yamada-Harada

Matsubayashi

et al. 2021

Pharmacoepidemiology and Drug

View full text Add to dashboard Cite

show abstract

“…13 According to a systematic review of validation studies of claims data in the Asia-Pacific region, only 7 validation studies have been done in Taiwan, and all these studies focused on cardiovascular diseases. 14 Regarding HBV and HCV, only 4 studies examined the validity of using International Classification of Diseases (ICD), Ninth Revision, Clinical Modification (ICD-9-CM) codes to identify patients with HBV or HCV infection. [15][16][17][18] The data used in 2 studies were confined to one medical center.…”

Section: Introductionmentioning

confidence: 99%

<p>Validity of ICD-10-CM Codes Used to Identify Patients with Chronic Hepatitis B and C Virus Infection in Administrative Claims Data from the Taiwan National Health Insurance Outpatient Claims Dataset</p>

Sheu¹,

Liang²,

Li³

et al. 2020

CLEP

View full text Add to dashboard Cite

Purpose: To validate the use of International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) codes to identify patients with chronic hepatitis B virus (HBV) and hepatitis C virus (HCV) infection in the Taiwan National Health Insurance (NHI) Outpatient Claims Dataset. Methods: We conducted a retrospective study using results of HBV surface antigen (HBsAg), HBV e antigen (HBeAg), and anti-HCV antibody tests in the NHI Lab & Exam Dataset from January 1 to March 31, 2018, as the reference standard to confirm HBV and HCV infection cases. We calculated sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) to assess the performance of HBV infection-specific ICD-10-CM codes (B180, B181, and B191) and HCV infection-specific ICD-10-CM codes (B182 and B192) recorded in the NHI Outpatient Claims Dataset to identify patients with HBV or HCV infection. Results: In total, 196,635 and 120,628 patients had analyzable results for HBsAg/HBeAg tests and anti-HCV tests, respectively. Moreover, 44,574 and 14,443 were confirmed to have HBV and HCV infection, respectively. The sensitivity, specificity, PPV, and NPV were, respectively, 46%, 83%, 45%, and 84% for HBV infection-specific ICD-10-CM codes and 47%, 99%, 81%, and 93% for HCV infection-specific ICD-10-CM codes. The sensitivity demonstrated great variation by region, clinical setting, and physician specialty. Conclusion: The HBV and HCV infection-specific ICD-10-CM codes recorded by physicians in Taiwan NHI outpatient claims data in 2018 had moderate sensitivity and high specificity for both HBV and HCV infection. The PPV was high for HCV ICD-10-CM codes, yet moderate for HBV ICD-10-CM codes.

show abstract

“…The clinical guidelines and guidance published in Japan have covered the fields of almost all infectious diseases. Research conducted using sales data and NDB were useful for the estimation of total antimicrobial use in Japan, though the estimated quantity of prescribing per diagnosis and its validity may not be reliable due to the nature of the administrative claims database (e.g., lack of validation of diagnostic codes, linkage of other data sets such as microbiology data-bases, and granularity of clinical data) (45, [60][61][62]. As such, at this stage, the effect of necessary and unnecessary antimicrobial use on the health outcomes can only be estimated through individual-based research.…”

Section: Discussionmentioning

confidence: 99%

Narrative Review: The Process of Expanding the Manual of Antimicrobial Stewardship by the Government of Japan

Jindai

Kusama

et al. 2021

Intern. Med.

View full text Add to dashboard Cite

The Ministry of Health, Labour and Welfare has published the Manual of Antimicrobial Stewardship (1st edition) in June 2017 to improve the prescribing practice of antimicrobials for immunocompetent adult and pediatric (both school-aged and older children) patients. Due to the increasing demand for further promoting outpatient antimicrobial stewardship, we conducted a literature and national guideline review to identify the area of need. The results of our review revealed a high antimicrobial prescription rate in the Japanese pediatric population. Furthermore, although the Japanese clinical guidelines/guidance covered the fields of almost all infectious diseases, no system exists to estimate the incidence and treatment patterns of important infectious diseases such as asymptomatic bacteriuria, skin and soft tissue infections, and dental practices in Japan. Therefore, addressing the issues of both establishing surveillance systems and the implementation of guidelines/guidance can be the next step to promote further outpatient antimicrobial stewardship.

show abstract

Validation studies of claims data in the Asia‐Pacific region: A comprehensive review

Cited by 33 publications

References 46 publications

Accuracy of Japanese claims data in identifying diabetes‐related complications

Accuracy of Japanese claims data in identifying diabetes‐related complications

<p>Validity of ICD-10-CM Codes Used to Identify Patients with Chronic Hepatitis B and C Virus Infection in Administrative Claims Data from the Taiwan National Health Insurance Outpatient Claims Dataset</p>

Narrative Review: The Process of Expanding the Manual of Antimicrobial Stewardship by the Government of Japan

Contact Info

Product

Resources

About